Dr. Arie Perry, director of neuropathology at UCSF, specializes in diagnosing benign and cancerous tumors of the nervous system, including those of the brain, spinal cord and peripheral nerves. He is also a specialist in classifying the molecular genetics of the tumors, which can be used to help determine the best treatment. He maintains an international consultation service for challenging cases involving brain tumor diagnosis.
Perry's research focuses on developing biomarkers (substances that indicate a condition) to enhance diagnosis, prognosis and management of patients with brain tumors. He played a leading role in setting the agreed-upon diagnostic guidelines for benign and cancerous nervous system tumors published by the World Health Organization.
Perry earned his medical degree and completed a residency in pathology at the University of Texas Southwestern. He completed fellowships in surgical pathology and neuropathology at the Mayo Clinic in Rochester, Minnesota.
Perry serves as director of UCSF's fellowship training program in neuropathology. He has won numerous teaching awards and authored various publications, including the textbook Practical Surgical Neuropathology. He is a member of several professional organizations, including the American Association of Neuropathologists, International Society of Neuropathology, Canadian Association of Pathologists and Society for Neuro-Oncology.